Modifiers: Get Familiar With Modifier JW Use in OPPS Settings

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.

Article Overview

This premium article reviews Medicare guidance on modifier JW for reporting discarded drug and biological amounts in outpatient and hospital-based facility settings. It focuses on how the modifier is discussed by CMS, where it applies, where it does not apply, and how OPPS status indicators affect reporting. The article is intended for coders, billers, and revenue cycle staff who work with outpatient drug claims and need a practical overview of the policy landscape.

Why This Topic Matters

Accurate reporting of discarded drugs and biologicals affects claim completeness and compliance in outpatient and hospital-based settings. Understanding the differences among facility types and OPPS payment categories helps billing staff recognize when modifier JW is relevant.

Article Sections

  1. Refresh Your Modifier JW Knowledge

    Introduces CMS guidance on the modifier and its role in Medicare Part B drug claims. Provides a general overview of the policy framework for discarded amounts of drugs and biologicals.

  2. Apply Modifier JW for Single-Use Vials, Packing

    Discusses the types of drug packaging and labeling considerations associated with the modifier. Also touches on documentation and facility supply distinctions.

  3. Know When Not to Append JW

    Covers situations and facility settings where the modifier is not used, along with references to Medicare manual guidance. Includes broader discussion of reporting contexts such as outpatient and inpatient claim environments.

  4. Factor in OPPS Status Indicators

    Reviews how OPPS status indicators relate to separately payable drugs and packaged items. Explains that facility reporting considerations vary based on the payment category.

  5. Consider This Modifier JW Example

    Presents an illustrative outpatient drug reporting scenario tied to modifier use and line-level claim reporting. The example shows how the article applies the broader guidance in practice.

What You Will Learn

  • How CMS frames modifier JW in Medicare Part B drug claims
  • Which outpatient and hospital-based settings are discussed in relation to discarded drugs and biologicals
  • How OPPS status indicators relate to reporting considerations for discarded drug amounts
  • What kinds of facility and documentation factors are highlighted in the article
  • How the article uses an example to illustrate outpatient drug reporting concepts

Who Should Read This

  • Medical coders
  • Outpatient facility billers
  • Hospital revenue cycle staff
  • Compliance staff
  • Medicare claims professionals

Codes Discussed

Modifiers Discussed


Subscribe or sign in to view the full article.

You have ED coding questions, and we deliver money-in-the-bank answers to help you defeat your claim issues and secure optimal reimbursement.

Stay in the know and avoid federal reproach with your subscription to TCI’s ED Coding and Reimbursement Alert.

  • Current newsletters added each month
  • Fully searchable archives - over 2100 articles
  • ALL years/issues back to 1998 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

Related Articles

Articles are listed in order of calculated relevance.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?